Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucosal macrophage subsets of the gut in HIV: decrease in antigen-presenting cell phenotype

S G Lim1, A Condez, L W Poulter

  • 1University Department of Medicine, Royal Free Hospital School of Medicine, London, UK.

Clinical and Experimental Immunology
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: hepatocellular carcinoma risk in the era of direct-acting anti-virals-is the case closed?

Alimentary pharmacology & therapeutics·2017
Same author

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.

Alimentary pharmacology & therapeutics·2016
Same author

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Hepatology international·2015
Same author

Editorial: patients' preferences and health utility assessment in those with HCV treated with sofosbuvir - stating the obvious?

Alimentary pharmacology & therapeutics·2014
Same author

Editorial: IDASPHERE phase I trial for chemoembolisation of HCC.

Alimentary pharmacology & therapeutics·2014
Same author

Commentary: vitamin D deficiency and liver cancer - cause, effect or myth?

Alimentary pharmacology & therapeutics·2014

HIV infection significantly decreases antigen-presenting dendritic cells in the gut lining across all disease stages. This compromises mucosal immunity, potentially increasing opportunistic gut infections in HIV patients.

Area of Science:

  • Immunology
  • Gastroenterology
  • Virology

Background:

  • HIV infection profoundly impacts the immune system, particularly mucosal immunity.
  • Macrophages in the intestinal lamina propria play a crucial role in local immune responses.

Purpose of the Study:

  • To investigate the effect of Human Immunodeficiency Virus (HIV) infection on intestinal lamina propria macrophage subsets.
  • To determine if HIV infection alters the density or function of specific macrophage populations in the gut.

Main Methods:

  • Analysis of duodenal biopsies from 41 HIV-infected patients (17 asymptomatic, 24 AIDS).
  • Immunohistochemical staining using monoclonal antibodies (MoAbs) for macrophage subsets (CD68, RFD1, RFD7) and HIV proteins (p24, p17, gp120).
  • Double immunofluorescence and assessment of HLA-DR expression to identify HIV-infected cells and 'suppressor' macrophages.

Related Experiment Videos

Main Results:

  • A significant decrease in dendritic cells (RFD1+ cells) was observed in all stages of HIV infection.
  • No significant difference in overall macrophage density (CD68+ cells) or mature phagocytic macrophages (RFD7+ cells) was found.
  • HLA-DR expression intensity on lamina propria cells remained unchanged; very few HIV-infected cells were identified.

Conclusions:

  • HIV infection severely compromises the antigen-presenting capacity of the gut mucosa due to reduced dendritic cells.
  • This impairment of mucosal immune defense exacerbates existing immune deficits from CD4+ T lymphocyte loss.
  • Reduced mucosal immunity may contribute to the increased risk of opportunistic infections in the gastrointestinal tract of HIV patients.